Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU
Chronic Obstructive Pulmonary Disease
About this trial
This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring Respiration, Artificial, weaning, critical care
Eligibility Criteria
Inclusion Criteria:
- COPD patients intubated and mechanically ventilated for less than 24 hours (Including patients who received NIV before intubation)
- Age > 18 years
- Written and/or informed consent
Exclusion Criteria:
- Septic shock
- Tracheostomy and/or home mechanical ventilation
- Expected poor short term prognosis
- Cardiac arrest with a poor neurological prognosis
- ARDS
- Broncho-pleural fistula
Sites / Locations
- Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intellivent ASV
PCV+PSV
Patients in this arm will be ventilated with Intellivent ASV. Intellivent ASV is an automatic close loop ventilation mode. FiO2 setting will be automatically adjusted according to patients SpO2 and minute volume will be automatically adjusted according to patients EtCO2.
PCV+PSV is a conventional ventilation strategy of pressure controlled ventilation PCV) and pressure support ventilation (PSV).In this arm, FiO2, pressure control levels, respiratory frequency and all the ventilator settings will be manually adjusted by the physicians in charge.